Turkey Company News: Merck’s Big Plans, Abdi Ibrahim Heads To Algeria
This article was originally published in PharmAsia News
Merck Consumer Health increases its focus on Turkey. Abdi Ibrahim makes a strategic move in the Algerian market. Turk Ilac ve Serum Sanayi A.Ş signs an agreement with the University of Ankara to develop and produce vaccines in Turkey. Pharmacists get worried about Alliance Boots’ intentions for Turkish market.
You may also be interested in...
Medtech Procurement A Victim Of Turkey’s Ongoing Economic Troubles
The devaluation of the Turkish Lira since May is making imports of medical devices more expensive and putting hospital procurement under renewed pressure. The local medtech industry associations TUMDEF and ARTED describe the problems ̶ and the solutions ̶ to Medtech Insight.
A Bright Moment At Last In Turkish Medtech Debt Payments Saga
Turkish medtechs’ demands for payment of their outstanding hospital debts went unheeded in 2021, but the government has finally started a payment process. It is not evenly applied, and has started in a small way, but the industry feels encouraged on more than one count.
Turkish Health System Slides Into Crisis After Devaluation Of Lira
Amid delays in surgical operations caused by shortages of equipment and medtech companies demanding payment of outstanding hospital debts, a strong devaluation of the Turkish lira has put the local health care system on a crisis footing.